Results 91 to 100 of about 7,946 (150)

Breaking the habit: Evidence-based approaches to smoking cessation. [PDF]

Bioinformation
Murella S, Kaur H, Gunti V, Polakala T, Kanani R, Juttu GK.   +5 more
europepmc   +1 more source

Understanding varenicline function via key receptor and ligand interactions.

Cell Rep Phys Sci
Aiken SG, Fiorito D, Harper M, Pikus G, Underhill J, Murray J, Rawlinson J, O'Donoghue AC, Gotti C, Lummis SCR, Minguez Viñas T, Viscarra F, Bermudez I, Gallagher T, Oliveira ASF.   +14 more
europepmc   +1 more source

Pharmacological interventions for alcohol use disorder: novel insights from recent clinical trials. [PDF]

Expert Rev Clin Pharmacol
McManus KR, Ray LA.
europepmc   +1 more source

Post-Cessation Weight Gain Across Smoking Cessation Therapies: A Review of Secondary Analyses from the ZESCA, EVITA, and E3 Trials. [PDF]

Int J Environ Res Public Health
Lelièvre A, Zolotarova T, Eisenberg MJ.
europepmc   +1 more source

The clinical usefulness of knowing <i>CHRNA5</i> polymorphism genotype: paving the way for personalized therapy. [PDF]

Tumori
Colombo F, Veronese C, Munarini E, Paolino C, Maspero D, Mangano N, Esposito M, Minnai F, Noci S, Giussani M, Morelli D, Cardani E, Esposito A, Sacco GGA, Spitaleri D, Boffi R.   +15 more
europepmc   +1 more source

Daily Cigarette Abstinence and Smoking Rate With Varenicline: Relationships With Treatment, Craving, and Affect During the First Week of the Quit Attempt. [PDF]

Nicotine Tob Res
Tonkin SS, Betts JM, Dowd AN, Mahoney MC, Cinciripini PM, Schnoll RA, George TP, Tyndale RF, Hawk LW.   +8 more
europepmc   +1 more source

Sex-Specific Mediation of Pre-Quit Smoking Reduction: Secondary Analysis of a Randomized Controlled Trial Extending Varenicline Preloading. [PDF]

Nicotine Tob Res
Johnstone S, Cooper RK, Wray JM, Tonkin S, Knapp KS, Colder CR, Maguin E, Mahoney MC, Tiffany ST, Brandon TH, Ashare RL, Hawk LW.   +11 more
europepmc   +1 more source

Characterization of Tobacco Cessation Services, Pharmacotherapies, and Policies at Adolescent-serving Substance Use Treatment Facilities in 2023. [PDF]

J Addict Med
Vidyasagar N, Whitney E, Brett E, Ogunniyi V, Beem A, Richardson A, King A, Fridberg DJ, Ari M.   +8 more
europepmc   +1 more source

Drug-Induced Autoimmune Hepatitis by Varenicline and Infliximab as a Continuous Disease Spectrum with Two Different Flares: Acute Liver Injury Followed by Hepatic Autoimmunity. [PDF]

Int J Mol Sci
Teschke R.
europepmc   +1 more source

Cannabis Use and Nicotine Vaping Cessation Outcomes: A Secondary Analysis of a Randomized Clinical Trial.

JAMA Netw Open
Gilman JM, Cather C, Reeder HT, Evohr B, Pachas GN, Gray KM, McClure EA, Schuster RM, Evins AE.   +8 more
europepmc   +1 more source